CN Patent

CN101001631B — 利用连续给予雌激素的避孕方案的激素治疗方法

Assigned to Teva Womens Health Inc · Expires 2014-08-06 · 12y expired

What this patent protects

本发明提供避孕方案，其中，给予雌性动物雌激素和孕激素的组合剂型，接着给予一段时间的雌激素。可对雌性动物实施所公开的避孕方案，作为提供非避孕益处的方法。

USPTO Abstract

本发明提供避孕方案，其中，给予雌性动物雌激素和孕激素的组合剂型，接着给予一段时间的雌激素。可对雌性动物实施所公开的避孕方案，作为提供非避孕益处的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN101001631B
Jurisdiction: CN
Classification: —
Expires: 2014-08-06
Drug substance claim: No
Drug product claim: No
Assignee: Teva Womens Health Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.